Project Grant R34HL186483
Award Date 7/25/26
Completion Date 5/31/29
Dollars Obligated $277K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Bloomington, IN 47405, USA
Similar Awards
- The National Heart, Lung, and Blood Institute awarded Trustees of Indiana University $249,000 on July 24, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to examine the role of structural factors in cardiovascular disease disparities. The recipient will employ data fusion techniques to create neighborhood-level structural determinants by harmonizing administrative datasets with prospective cohort data from the Women's Health Initiative (WHI). The analysis will link WHI...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Indiana University Indianapolis a Project Grant of $169,444.00 under the Cardiovascular Diseases Research program (CFDA 93.837) beginning September 5, 2025, with completion targeted for August 31, 2030. This award supports the co-development and pilot testing of a stress management intervention designed specifically for Black adults with elevated blood pressure and hypertension. The research addresses...
- The National Heart, Lung, and Blood Institute awarded the Trustees of Indiana University $1,484,930 on June 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and validate a behavioral large language model that identifies prescriptions of guideline-directed medical treatments for peripheral artery disease-related claudication in electronic health records. The project addresses suboptimal clinical implementation of proven non-invasive behavioral and pharmacologic...
- The National Heart, Lung, and Blood Institute awarded Northwestern University $120,000 under Cardiovascular Diseases Research (CFDA 93.837) on August 13, 2026, for MITRA (Motivating Incentives to Increase Physical Activity), a project grant addressing low physical activity rates among South Asian adults with high cardiovascular disease burden. The project evaluates the acceptability of six behavioral economics-based intervention strategies—social incentives, gamification, commitment devices,...
- The National Heart, Lung, and Blood Institute, a component of the Department of Health and Human Services National Institutes of Health, awarded $792,498 to the Trustees of Indiana University (doing business as Indiana University Indianapolis) on August 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate gene-environment interactions in congenital heart disease, specifically the role of maternal obesity in offspring cardiac development. The research...
- The National Heart, Lung, and Blood Institute awarded the Trustees of Indiana University $516,592 on July 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct integrative genomic analysis and develop high-dimensional risk prediction models for congenital heart defects using random field methods. The research leverages existing biospecimens and data from the National Birth Defect Prevention Studies, the Pediatric Cardiac Genomics Consortium, and the Trans-Omics for...
- The National Heart, Lung, and Blood Institute awarded Rowan University $271,250 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a pilot trial testing physical activity partnerships for midlife women with elevated cardiovascular disease risk. The award funds a 12-week physical activity skills coaching program using intensive ambulatory assessment. The trial will enroll 160 insufficiently active women ages 40–65 with one or more CVD risk factors...
- The National Heart, Lung, and Blood Institute awarded Trustees of Indiana University $161,645 on August 5, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and pilot-test the Latino Intervention Support to Succeed (LISTOS) psychosocial intervention, designed to improve capability, opportunity, and motivation for Latino individuals to participate in and adhere to the Diabetes Prevention Program. The award supports Dr. Ines Gonzalez Casanova, an assistant professor...
- The National Heart, Lung, and Blood Institute awarded Brown University $801,800 on June 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to evaluate the Health Zones Initiative, a statewide community intervention model in Rhode Island designed to improve diet quality, physical activity, and cardiovascular disease outcomes across 14 communities. The project will assess the effectiveness, implementation, and interaction between implementation and effectiveness of the...
- The National Heart, Lung, and Blood Institute awarded Duke University $242,250 on June 18, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a secondary analysis identifying genetic predictors of physical activity intervention dropout and adherence. The project will analyze existing data from two completed physical activity interventions—the Heart Health Study and the HF-ACTION Trial—to identify genetic variants associated with intervention dropout and adherence...